A spectrum is a photograph of an ion, not of a molecule
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 3 of 5 of this archive, newest first.
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
The document is four pages. Three of them are about dates.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Receptor pharmacology is strong on average effects and almost silent on individual variation. That gap is where most reader questions live.
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth climbing.
The observation that closes a facility is rarely the dramatic one.
The route did not close because of a rule about peptides.
The result is unremarkable. What the report omits is not.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A pharmacist catches most of these in licensed practice. In this market there is no pharmacist, so the checks have to be structural.
What was pre-specified, what was exploratory, and what was calculated afterwards by people who did not run the trial.
The observation that closes a facility is rarely the dramatic one.
The route did not close because of a rule about peptides.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
A monitoring schedule requires evidence about incidence. For this population, that evidence does not exist.
What a laboratory can and cannot know about the provenance, storage history and representativeness of what lands on its bench.
The evidence base is thin and the document says so, which is to its credit.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Endotoxin is the more tractable of the two questions, and a kinetic chromogenic determination is neither slow nor exotic. It is simply not on the menu.
A plausible mechanism, a measurable change, and no outcome data. This is what an open question looks like.
Column chemistry, particle size and pore diameter determine what the separation is capable of before the gradient is even programmed.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
Reported from the sessions, and from the two hours afterwards.
Deamidation, oxidation, aggregation and hydrolysis account for nearly all of what happens to a peptide over time. Each has a characteristic residue, a characteristic…
Follow the resin, not the catalogue.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
Reported from the analysis, not from a warning notice.
What scintigraphy and breath-test studies established about emptying rate, and what they did not.
Nausea and gastric delay attenuate over weeks at an unchanged dose. That single physiological fact is the entire justification for holding.